Kabat G C, Silvera S A Navarro, Miller A B, Rohan T E
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, NY 10461, USA.
Br J Cancer. 2007 Mar 12;96(5):845-9. doi: 10.1038/sj.bjc.6603629. Epub 2007 Feb 20.
We examined the association of reproductive and hormonal factors with renal cell cancer risk in a cohort study of 89 835 Canadian women. Compared with nulliparous women, parous women were at increased risk (hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.02-3.09), and there was a significant gradient of risk with increasing levels of parity: relative to nulliparous women, women who had > or =5 pregnancies lasting 4 months or more had a 2.4-fold risk (HR=2.41, 95% CI=1.27-4.59, P for trend 0.01). Ever use of oral contraceptives was associated with a modest reduction in risk. No associations were observed for age at first live birth or use of hormone replacement therapy. The present study provides evidence that high parity may be associated with increased risk of renal cell cancer, and that oral contraceptive use may be associated with reduced risk.
在一项针对89835名加拿大女性的队列研究中,我们研究了生殖和激素因素与肾细胞癌风险之间的关联。与未生育女性相比,生育过的女性风险增加(风险比(HR)为1.78,95%置信区间(CI)为1.02 - 3.09),并且随着产次水平的增加存在显著的风险梯度:相对于未生育女性,怀孕≥5次且持续4个月或更长时间的女性风险是2.4倍(HR = 2.41,95% CI = 1.27 - 4.59,趋势检验P值为0.01)。曾经使用口服避孕药与风险适度降低相关。首次活产年龄或使用激素替代疗法未观察到关联。本研究提供了证据表明高生育次数可能与肾细胞癌风险增加相关,而使用口服避孕药可能与风险降低相关。